CurtisLHDemberLMVazquezMA, et al. Addressing guideline and policy changes during pragmatic clinical trials. Clin Trials, this issue.
2.
IoannidisJPFanelliDDunneDD, et al. Meta-research: evaluation and improvement of research methods and practices. PLoS Biol2015; 13(10): e1002264.
3.
ChalmersIGlasziouP. Avoidable waste in the production and reporting of research evidence. Lancet2009; 374(9683): 86–89.
4.
National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. London: NICE, 2013.
5.
AbuHilalMAldrighettiLDagherI, et al. The Southampton consensus guidelines for laparoscopic liver surgery: from indication to implementation. Ann Surg2018; 268(1): 11–18.
6.
PatsopoulosNA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci2011; 13(2): 217–224.
7.
RafteryJYoungAStantonL, et al. Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme. Health Technol Assess2015; 19(11): 1–138.
OngaroEFerreFFattoreG. The fiscal crisis in the health sector: patterns of cutback management across Europe. Health Policy2015; 119(7): 954–963.
10.
DuttonSJKenealyNLoveSB, et al. FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer. BMC Cancer2014; 14: 497.
11.
NICE. Selective internal radiation therapy for non-resectable colorectal metastases in the liver, July2011, pp. 1–8, https://www.nice.org.uk/guidance/ipg401# (2013, accessed 31 March 2019).